Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 460-230-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
To assess the mutagenicity of EP-4000S results from three tests were used.
In the Reverse Mutation Assay: "Ames test" (Safepharm Laboratories Limited, 1997) the test material was tested up to the maximum recommended dose level of 5000 µg/plate. The mutagenic responses were predominantly observed to those tester strains sensitive to base-pair substitution in the genetic material.
EP-4000S was considered to be mutagenic under the conditions of this test.
The Chromosome Aberration Test (Huntingdon Life Sciences, 2012) was performed to assess the ability of EP-4000S to induce chromosomal aberrations in human lymphocytes cultured in vitro. The highest final concentration of EP-4000S used for testing was 3450 μg/mL. In order to determine the toxicity to cultured human lymphocytes, the mitotic index was assessed for all cultures treated with the test substance and the vehicle control, ethanol.
It is concluded that EP-4000S has shown evidence of causing an increase in the frequency of structural chromosome aberrations in this in vitro cytogenetic test system, under the experimental conditions described.
EP-4000S was also tested for mutagenic potential in an In vitro mammalian cell mutation assay (Huntingdon Life Sciences, 2012). Toxicity was observed in the preliminary toxicity test. It was concluded that EP-4000S demonstrated mutagenic potential in this in vitro cell mutation assay, under the experimental conditions described.
This registration dossier has been prepared for tonnage band of up to 10 tonnes/year. An in-vitro bacterial reversre mutation test was conducted as required by Annex VII of REACH. As the initial test in bacteria was positive for mutagenic effects, further in-vitro testing was conducted (chromosome aberration and mammalian cell mutation tests as described above) within the scope permitted by Annex VII. Although the available tests all indicate mutagenic activity, in-vivo testing will not currently be considered on the basis that it is not warranted at this tonnage band; in the case that the tonnage band were to exceed 10 tonnes/year then in-vivo testing could be considered within the scope of Annex VIII of REACH.
Short description of key information:
EP-4000S was considered to be mutagenic.
Endpoint Conclusion: Adverse effect observed (positive)
Justification for classification or non-classification
As noted above, three in-vivo tests (including two tests in mammalian cells) indicated mutagenic activity in EP-4000S. The available results indicate a possible concern for mutagenicity in humans; on the basis of in-vitro results, including results from tests conducted in mammalian cells it is considered that EP-4000S meets the criteria for classification as Germ Cell Mutagen Category 2 according to the CLP Regulation (Regulation (EC) 1272/2008).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.